1. Reversible Cerebral Vasoconstriction Syndrome and Multisystem Inflammatory Syndrome in Children With COVID-19
- Author
-
Atefeh Sadeghizadeh, Zahra Pourmoghaddas, Alireza Zandifar, Seyedeh Zahra Tara, Hamid Rahimi, Rana Saleh, Saba Ramezani, Mohammadreza Ghazavi, Omid Yaghini, Neda Hosseini, Nahid Aslani, Mohammad Saadatnia, and Arastoo Vossough
- Subjects
Male ,Headache Disorders, Primary ,Multi-system inflammatory syndrome in children ,Short Communication ,reversible cerebral vasoconstriction syndrome ,COVID-19 ,Constriction, Pathologic ,Systemic Inflammatory Response Syndrome ,Cerebrovascular Disorders ,Developmental Neuroscience ,Neurology ,thunderclap headache ,Pediatrics, Perinatology and Child Health ,Humans ,Female ,Neurology (clinical) ,Child - Abstract
Background Multi-system inflammatory syndrome in children (MIS-C) involves multiple organs and shows increased inflammatory markers. Since the onset of the COVID-19 pandemic, several studies have reported the association between severe COVID-19 and MIS-C. Reversible cerebral vasoconstriction syndrome (RCVS) presents with thunderclap headaches and multifocal reversible vasoconstriction on imaging. RCVS is very rare in children. This paper reports two cases of pediatric COVID-19 with severe MIS-C and clinical and imaging features indicative of RCVS. Methods Clinical, laboratory and imaging data of the patients were reviewed. The diagnosis of RCVS was confirmed based on clinical symptomatology and brain magnetic resonance imaging findings. Results Two pediatric patients with clinical findings compatible with severe MIS-C and hemodynamic compromise presented to the hospital. During their hospitalization course, they developed thunderclap headaches and neurological deficits. Both were receiving vasoactive agents, intravenous immune globulin (IVIG), and immunosuppressants. Imaging studies showed marked multifocal cerebral vasoconstriction in both cases and infarcts in one. The course and management of the patients will be presented. After controlling inflammation and elimination of triggers, both patients were ultimately symptom-free upon discharge. Cerebral vasoconstriction had completely resolved on follow-up imaging. Conclusions Although a variety of symptoms including headaches may be seen in pediatric COVID-19 patients with MIS-C, RCVS should be considered as a differential diagnosis in cases of thunderclap headache accompanied by neurologic signs in these patients. Imaging findings and follow-up are also key in establishing the diagnosis.
- Published
- 2022